What our centre can offer towards this global effort:

• Established for over 20 years
• Phase II, III and IV Alzheimer’s studies
• Preclinical Alzheimer’s
• Prodromal Alzheimer’s
• MCI (Mild Cognitive Impairment)
• Mild/Moderate Alzheimer’s
• LP, CT, MRI and PET Evaluations
• Large Database
• APOE4 Carrier Database >1000 Carriers
• Amyloid Database

Parkinson’s programs now being evaluated – Phase II, III and IV

Do you have a new program in Alzheimer’s or Parkinson’s? Please contact us directly to discuss potential new programs.

Contact our Development Director, Alison Cranmer, at info@glasgowmemoryclinic.com